Internal Medicine, Endocrinology, Diabetes, & Metabolism · Houma, LA
NPI
1124194840
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
855 Belanger St, Suite 100
Houma, LA, 70360
Phone (985) 876-5451
Medicare paid, 2024
$49K
606 services
Medicare patients, 2024
231
Average age 74
Drug cost, 2024
$1.0M
4,545 prescriptions
Company payments, 2025
$1,103
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Sisam was code 99214 (office e&m - established), 594 times for 230 patients. In total David A Sisam billed 606 services in 4 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 594 | 230 | $80.51 | $48K |
By year: 2022 $62K for 1,185 services; 2023 $57K for 855 services; 2024 $49K for 606 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 146 | 97 | $3.13 | $457 |
| 83036 Blood Count | 28 | 28 | $9.52 | $267 |
Medicare prescription drug claims, 2024
In 2024, the drug David A Sisam prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 682 prescriptions and refills. In total David A Sisam wrote 4,545 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 682 | 1,153 | 127 | $47K |
| Levothyroxine Sodium Generic | 300 | 689 | 68 | $2,569 |
| Metformin Hcl Er Metformin Hcl | 225 | 500 | 52 | $2,544 |
| Metformin Hcl Generic | 177 | 438 | 45 | $1,297 |
| Jardiance Empagliflozin | 162 | 242 | 26 | $136K |
| Unithroid Levothyroxine Sodium | 148 | 232 | 26 | $5,970 |
| Ozempic Semaglutide | 145 | 155 | 22 | $140K |
| Alendronate Sodium Generic | 142 | 204 | 29 | $580 |
| Mounjaro Tirzepatide | 133 | 143 | 14 | $142K |
| Methimazole Generic | 114 | 226 | 22 | $779 |
| Liothyronine Sodium Generic | 107 | 224 | 25 | $4,850 |
| Farxiga Dapagliflozin Propanediol | 102 | 152 | 17 | $81K |
| Rosuvastatin Calcium Generic | 86 | 157 | 16 | $692 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 82 | 132 | 18 | $4,746 |
| Repaglinide Generic | 79 | 131 | 21 | $2,070 |
Brand drugs: 2,132 claims; generic drugs: 2,236 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Sisam $1,103 ($1,103 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $184.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 5 | $184 |
| Novo Nordisk Inc NVO | 8 | $183 |
| Amneal Pharmaceuticals LLC AMRX | 10 | $153 |
| Xeris Pharmaceuticals, Inc. | 6 | $128 |
| Antares Pharma, Inc. | 4 | $86.59 |
| Abbvie Inc. ABBV | 4 | $79.01 |
| Soleno Therapeutics, Inc. SLNO | 3 | $55.67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41.39 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $34.37 |
| Kyowa Kirin, Inc. 4151.T | 1 | $28.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.